Omax3® Celebrates 10 Years as Industry Leader in Omega-3 Formulations

Thursday, September 27, 2018 General News
Email Print This Page Comment bookmark
Font : A-A+

High purity, omega-3 fatty acids continue to show reductions in cardiovascular risk

SANTA MONICA, Calif., Sept. 27, 2018 /PRNewswire-PRWeb/ -- Today, Amarin released the long-awaited results of the Vascepa®

(icosapent ethyl) REDUCE-IT trial, further validating Omax3®'s 10-year position, that high-concentrate omega 3 fatty acids have a profound and lasting effect on cardiovascular health.

This comes at an important time, as Omax Health celebrates the 10-Year Anniversary since launching their patented Omax3 Ultra-Pure Omega-3 Supplement. Omax3 was developed by Yale-affiliated scientists to bring pharmaceutical grade products direct to the consumer. The product is known for its 93.9% omega-3 content, with exceptional purity, and an optimized 4:1 ratio of EPA to DHA. In preliminary studies, the high-concentration formulation demonstrated inhibition of key inflammatory marketers and triglyceride lowering properties.

In 2000, the FDA announced a qualified health claim for dietary supplements containing EPA and DHA omega-3 fatty acids and the reduced risk of Cardiovascular Disease. Now Amarin's Pure EPA Vascepa REDUCE-IT trial adds to the body of scientific evidence for high-concentration omega-3s and cardiovascular health. Amarin reported that the omega-3 fish oil prescription capsule called Vascepa significantly reduced the risk of serious cardiovascular events in 8,179 statin-treated patients over nearly 5 years.*

"This is a landmark moment for the health and wellness industry," said Evan DeMarco, Omax Health's Chief Marketing Officer and Product Innovator. "Although Vascepa is a pharmaceutical drug, this groundbreaking study further validates the safety and efficacy of Omax3's pharmaceutical grade omega-3 dietary supplement."

Omax Health has been a pioneer in bringing innovative and scientifically validated dietary supplements to consumers who care about what they put in their bodies, including Omax Stress Remedy, their newest CBD fusion supplement.

ABOUT OMAX® HEALTH Omax® Health is a leading nutraceuticals company focused on developing premium, science-based supplements including Omax3®, The Ultra-Pure Omega-3 Supplement that has become the industry leader in omega-3 products. Founded by Yale-affiliated scientists, Omax® Health has since expanded to a global health and wellness company committed to delivering exceptionally pure, concentrated, and third-party tested products that are trusted by thousands of consumers, athletes, and healthcare practitioners. Omax Health's products are designed to optimize health and vitality, so you can live #lifetothemax. For additional information, please visit http://www.omaxhealth.com.

 

SOURCE Omax Health, Inc.



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store